Glaucoma 360 2018

Glaucoma 'renaissance' builds from expanding surgical optionsUntil now, surgery has been considered a second-line treatment after medication and lasers because of the risks associated with trabeculectomy and tube shunts. Now ophthalmologists can draw from a larger surgical tool chest, explains Iqbal Ike K. Ahmed, MD.
Ophthalmologists called upon to help impaired colleaguesOphthalmologists must take an active role in preventing impaired colleagues from hurting patients, according to Terri Pickering, MD.
How advances in phaco benefit glaucoma surgeryAdvances in phacoemulsification are creating new opportunities for glaucoma surgery, especially in developing countries, according to Alan S. Crandall, MD.
Shaffer Prize report goes down one path, but leads to anotherResearch aiming to elucidate the underlying factors for oxidative damage to the trabecular meshwork in glaucoma has led to studies of alterations in gene expression that may ultimately guide the development of genetic therapy for glaucoma, said Carla J. Siegfried, MD, recipient of the 2018 Shaffer Prize for Innovative Glaucoma Research.
What advent of MIGS means for earlier glaucoma interventionIn addition to making use of MIGS, interventional glaucoma might utilize other novel drainage devices and sustained drug-delivery devices and be combined with cataract surgery. This approach is more proactive, aims at lower IOP, lowers risk and addresses adherence, said Iqbal Ike K. Ahmed, MD.
Virtual reality on the horizon for treatment of glaucomaOne laboratory is at work on new devices that use visual stimuli to prompt retinal ganglion cells to regenerate, while two other researchers describe techniques through which virtual reality might diagnose the disease more accurately than standard automated perimetry.
Annual Gala to 'Celebrate' with 'The Cure in Sight'Glaucoma 360, a three-day event held by the Glaucoma Research Foundation (GRF), launched its seventh year Thursday night with the Glaucoma 360 Annual Gala that attracted more than 400 people to the Palace Hotel in San Francisco.
Glaucoma Symposia aim to 'Educate' with 2 sessionsGlaucoma 360, a three-day event organized by the Glaucoma Research Foundation (GRF) will move into its final day on Saturday with the Glaucoma Symposium. The focus will shift from "Innovate" to "Educate." Two continuing medical education sessions are-one for ophthalmologists in the morning and another for optometrists in the afternoon.
New Horizons Forum breaks ground to 'Innovate'Glaucoma 360, a three-day event being held here by the Glaucoma Research Foundation (GRF), will move from its "Celebrate" phase with Annual Gala on Thursday into its "Innovate" phase with the New Horizons Forum set for today. This event is a full day of presentations, panels, and discussions featuring leaders from start-up companies, industry executives, ophthalmic experts, venture capitalists, and the FDA.
Identifying glaucoma-related visual function lossA portable device for detecting multifocal steady-state visual evoked potentials associated with visual field stimulation is being developed as an objective test for identifying glaucoma-related visual function loss.